ArticleCell cycle (Georgetown, Tex.)2011

Targeting JunD: a potential strategy to counteract hormone-refractory prostate cancer.

Devanand Sarkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.